BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17874089)

  • 1. Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia.
    Nakajima T; Ohtani H; Naruse T; Shibata H; Mimaya JI; Terunuma H; Kimura A
    Immunogenetics; 2007 Oct; 59(10):793-8. PubMed ID: 17874089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL3L1 copy number variation and susceptibility to HIV-1 infection: a meta-analysis.
    Liu S; Yao L; Ding D; Zhu H
    PLoS One; 2010 Dec; 5(12):e15778. PubMed ID: 21209899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C.
    Grünhage F; Nattermann J; Gressner OA; Wasmuth HE; Hellerbrand C; Sauerbruch T; Spengler U; Lammert F
    J Hepatol; 2010 Feb; 52(2):153-9. PubMed ID: 20044164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of CCL3L1 copy number in an HIV-1-infected white population.
    Lee EY; Yue FY; Jones RB; Lo C; Sheth P; Hyrcza MD; Kovacs C; Benko E; Kaul R; Ostrowski M
    AIDS; 2010 Jun; 24(10):1589-91. PubMed ID: 20442635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians.
    Rathore A; Chatterjee A; Sivarama P; Yamamoto N; Singhal PK; Dhole TN
    AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1149-56. PubMed ID: 19886839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans.
    Aklillu E; Odenthal-Hesse L; Bowdrey J; Habtewold A; Ngaimisi E; Yimer G; Amogne W; Mugusi S; Minzi O; Makonnen E; Janabi M; Mugusi F; Aderaye G; Hardwick R; Fu B; Viskaduraki M; Yang F; Hollox EJ
    BMC Infect Dis; 2013 Nov; 13():536. PubMed ID: 24219137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-specific profiling of CCL3L1 copy number of the three major ethnic groups in Malaysia and the implication on HIV susceptibility.
    Mohamad Isa II; Jamaluddin J; Achim NH; Abubakar S
    Gene; 2020 Sep; 754():144821. PubMed ID: 32497559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.
    Ahuja SK; Kulkarni H; Catano G; Agan BK; Camargo JF; He W; O'Connell RJ; Marconi VC; Delmar J; Eron J; Clark RA; Frost S; Martin J; Ahuja SS; Deeks SG; Little S; Richman D; Hecht FM; Dolan MJ
    Nat Med; 2008 Apr; 14(4):413-20. PubMed ID: 18376407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental aspects of copy number variant assays at CCL3L1.
    Field SF; Howson JM; Maier LM; Walker S; Walker NM; Smyth DJ; Armour JA; Clayton DG; Todd JA
    Nat Med; 2009 Oct; 15(10):1115-7. PubMed ID: 19812562
    [No Abstract]   [Full Text] [Related]  

  • 10. CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals.
    Kulkarni H; Agan BK; Marconi VC; O'Connell RJ; Camargo JF; He W; Delmar J; Phelps KR; Crawford G; Clark RA; Dolan MJ; Ahuja SK
    PLoS One; 2008 Sep; 3(9):e3165. PubMed ID: 18776933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replication.
    Pilotti E; Elviri L; Vicenzi E; Bertazzoni U; Re MC; Allibardi S; Poli G; Casoli C
    Blood; 2007 Mar; 109(5):1850-6. PubMed ID: 17062725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL3L1 and CCL4L1: variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection.
    Shao W; Tang J; Song W; Wang C; Li Y; Wilson CM; Kaslow RA
    Genes Immun; 2007 Apr; 8(3):224-31. PubMed ID: 17330138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-B polymorphism in Japanese HIV-1-infected long-term surviving hemophiliacs.
    Munkanta M; Terunuma H; Takahashi M; Hanabusa H; Miura T; Ikeda S; Sakai M; Fujii T; Takahashi Y; Oka S; Matsuda J; Ishikawa M; Taki M; Takashima Y; Mimaya J; Ito M; Kimura A; Yasunami M
    Viral Immunol; 2005; 18(3):500-5. PubMed ID: 16212528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users.
    Huik K; Sadam M; Karki T; Avi R; Krispin T; Paap P; Rüütel K; Uusküla A; Talu A; Abel-Ollo K; Lutsar I
    J Infect Dis; 2010 Mar; 201(5):730-9. PubMed ID: 20095832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.
    Gonzalez E; Kulkarni H; Bolivar H; Mangano A; Sanchez R; Catano G; Nibbs RJ; Freedman BI; Quinones MP; Bamshad MJ; Murthy KK; Rovin BH; Bradley W; Clark RA; Anderson SA; O'connell RJ; Agan BK; Ahuja SS; Bologna R; Sen L; Dolan MJ; Ahuja SK
    Science; 2005 Mar; 307(5714):1434-40. PubMed ID: 15637236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic factors that confer sensitivity to HAART in HIV-infected subjects: implication of a benefit of an earlier initiation of HAART.
    Nakajima T; Kimura A
    Pharmacogenomics; 2008 Sep; 9(9):1347-51. PubMed ID: 18781860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis.
    McKinney C; Merriman ME; Chapman PT; Gow PJ; Harrison AA; Highton J; Jones PB; McLean L; O'Donnell JL; Pokorny V; Spellerberg M; Stamp LK; Willis J; Steer S; Merriman TR
    Ann Rheum Dis; 2008 Mar; 67(3):409-13. PubMed ID: 17604289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL3L1 and HIV/AIDS susceptibility.
    Bhattacharya T; Stanton J; Kim EY; Kunstman KJ; Phair JP; Jacobson LP; Wolinsky SM
    Nat Med; 2009 Oct; 15(10):1112-5. PubMed ID: 19812561
    [No Abstract]   [Full Text] [Related]  

  • 19. CCL3L1 gene copy number in individuals with and without HIV-associated neurocognitive disorder.
    Brown A; Sacktor N; Marder K; Cohen B; Schifitto G; Skolasky RL; Creighton J; Guo L; McArthur JC
    Curr Biomark Find; 2012 Jan; 2012(2):1-6. PubMed ID: 23814703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to: "Experimental aspects of copy number variant assays at CCL3L1".
    He W; Kulkarni H; Castiblanco J; Shimizu C; Aluyen U; Maldonado R; Carrillo A; Griffin M; Lipsitt A; Beachy L; Shostakovich-Koretskaya L; Mangano A; Sen L; Nibbs RJ; Tiemessen CT; Bolivar H; Bamshad MJ; Clark RA; Burns JC; Dolan MJ; Ahuja SK
    Nat Med; 2009 Oct; 15(10):1117-20. PubMed ID: 19812563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.